Oramed Pharmaceuticals
ORMP
$2.30
Share price
-1.29%
Change (1 day)
-36.64%
Change (1 year)
Categories
Oramed Pharmaceuticals (ORMP) Fails to deliver data
Key failure to deliver metrics for Oramed Pharmaceuticals:
- Last SEC data release: 2024-04-30
- Last 15 days FTD volume: N/A
- Last 3 months FTD volume: $0.1 M
- Last year FTD volume: $2.74 M
Failures to deliver for Oramed Pharmaceuticals (ORMP) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Oramed Pharmaceuticals (ORMP) - since 2013
Volume in USD (price x number of shares), data since 2013Oramed Pharmaceuticals (ORMP) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.14 M | -97.18% |
| 2023 | $5.23 M | -82.2% |
| 2022 | $29.42 M | 15.91% |
| 2021 | $25.38 M | 418.21% |
| 2020 | $4.89 M | 429.07% |
| 2019 | $0.92 M | 29.09% |
| 2018 | $0.71 M | -73.46% |
| 2017 | $2.7 M | -85.35% |
| 2016 | $18.44 M | 118.71% |
| 2015 | $8.43 M | -34.36% |
| 2014 | $12.85 M | 166.85% |
| 2013 | $4.81 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Novo Nordisk NVO | $47.41 M | $0.11 B | 🇩🇰 Denmark |
 Sanofi SNY | $21.22 M | $52.23 M | 🇫🇷 France |
 Ultragenyx RARE | $1.01 M | $14.7 M | 🇺🇸 USA |
 Lexicon Pharmaceuticals
LXRX | $9.97 M | $24.04 M | 🇺🇸 USA |
 Compugen CGEN | $0.61 M | $2.28 M | 🇮🇱 Israel |